
Pharmac approves Ozurdex
Ozurdex, a long-acting intravitreal steroid, delivered via a sustained-release ocular implant is now available and funded for New Zealand adult diabetic macular oedema (DMO) patients, which is welcome news, say Kiwi retina specialists.












